Skip to main content
Top
Published in: Rheumatology International 3/2010

01-01-2010 | Short Communication

Mannose binding lectin levels are not related to radiographic damage in ankylosing spondylitis

Authors: Sibel Zehra Aydin, Pamir Atagunduz, Burak Erer, Cengiz Bahadir, Nevsun Inanc, Haner Direskeneli

Published in: Rheumatology International | Issue 3/2010

Login to get access

Abstract

In the current study we aimed to investigate the effect of MBL deficiency in radiographic damage of the spine in a large group of AS patients. One hundred and ninety-one AS patients and 85 healthy controls were studied. Disease activity, radiological scores, and demographic features were recorded. MBL levels were measured with standard ELISA kits. Results showed that median MBL levels in AS and healthy controls were 2,530 (range 0–5,861) ng/ml and 3,415 (0–7,950) ng/ml, respectively (p = 0.1). MBL deficiency (<500 ng/ml) was comparable in both groups (%21.5 in AS, % 17.6; p = 0.5). Disease activity, clinical picture, and therapies were not associated with MBL levels. Both BASRI and mSASSS scores were found similar in AS patients with or without MBL deficiency [BASRI: MBL < 500 ng/ml: 6(2–12), MBL ≥ 500 ng/ml: 6(2–12); p = 0.75], [mSASSS: MBL < 500 ng/ml: 3(0–72), MBL ≥ 500 ng/ml: 5(0–72); p = 0.81]. We conclude that MBL deficiency prevalence is not increased in AS patients and it is not a cause of a severe radiographic damage.
Literature
3.
go back to reference Ohlenschlaeger T, Garred P, Madsen HO, Jacobsen S (2004) Mannosebinding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med 351:260–267. doi:10.1056/NEJMoa033122 CrossRefPubMed Ohlenschlaeger T, Garred P, Madsen HO, Jacobsen S (2004) Mannosebinding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med 351:260–267. doi:10.​1056/​NEJMoa033122 CrossRefPubMed
4.
go back to reference Inanc N, Mumcu G, Birtas E et al (2005) Serum mannose-binding lectin levels are decreased in Behcet’s disease and associated with disease severity. J Rheumatol 32:287–291PubMed Inanc N, Mumcu G, Birtas E et al (2005) Serum mannose-binding lectin levels are decreased in Behcet’s disease and associated with disease severity. J Rheumatol 32:287–291PubMed
5.
go back to reference Mumcu G, Inanc N, Elbir Y, Ergun T, Yavuz S, Direskeneli H (2004) Low serum mannose binding lectin levels predispose to S. mutans colonization in Behçet’s disease. XI International Congress on Behçet’s Disease Mumcu G, Inanc N, Elbir Y, Ergun T, Yavuz S, Direskeneli H (2004) Low serum mannose binding lectin levels predispose to S. mutans colonization in Behçet’s disease. XI International Congress on Behçet’s Disease
8.
go back to reference Aydin SZ, Atagunduz P, Inanc N et al (2007) H Mannose binding lectin levels in spondyloarthropathies. J Rheumatol 34:2075–2077PubMed Aydin SZ, Atagunduz P, Inanc N et al (2007) H Mannose binding lectin levels in spondyloarthropathies. J Rheumatol 34:2075–2077PubMed
10.
go back to reference Saevarsdottir S, Vikingsdottir T, Vikingsson A, Manfredsdottir V, Geirsson AJ, Valdimarsson H (2001) Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis. A prospective study. J Rheumatol 28:728–734PubMed Saevarsdottir S, Vikingsdottir T, Vikingsson A, Manfredsdottir V, Geirsson AJ, Valdimarsson H (2001) Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis. A prospective study. J Rheumatol 28:728–734PubMed
Metadata
Title
Mannose binding lectin levels are not related to radiographic damage in ankylosing spondylitis
Authors
Sibel Zehra Aydin
Pamir Atagunduz
Burak Erer
Cengiz Bahadir
Nevsun Inanc
Haner Direskeneli
Publication date
01-01-2010
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 3/2010
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1189-8

Other articles of this Issue 3/2010

Rheumatology International 3/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.